Tatsuta M, Yamamura H, Iishi H, Noguchi S, Ichii M, Taniguchi H
Eur J Cancer Clin Oncol. 1985 Jun;21(6):741-4. doi: 10.1016/0277-5379(85)90272-x.
The effects of prolonged administration of tetragastrin from the beginning of intrarectal instillation of 1 ml of 0.25% N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and after MNNG-treatment on the incidence and histology of colonic tumors were compared in inbred Wistar rats. In week 35 prolonged administration of testragastrin in depot form from the beginning of MNNG-treatment resulted in a significant reduction in the incidence of colonic tumors and a significant increase in the incidence of mucinous adenocarcinoma, unlike the well-differentiated adenocarcinoma produced in controls without gastrin. In contrast, prolonged administration of tetragastrin after MNNG-treatment had little or no influence on the incidence, size or histology of colonic tumors. Thus tetragastrin had no promoting effect on colonic tumors.
在近交系Wistar大鼠中,比较了从开始直肠内注入1 ml 0.25%的N-甲基-N'-硝基-N-亚硝基胍(MNNG)起长期给予四肽胃泌素以及MNNG处理后给予四肽胃泌素对结肠肿瘤发生率和组织学的影响。在第35周时,从MNNG处理开始以长效剂型长期给予四肽胃泌素,导致结肠肿瘤发生率显著降低,黏液腺癌发生率显著增加,这与未给予胃泌素的对照组中产生的高分化腺癌不同。相比之下,MNNG处理后长期给予四肽胃泌素对结肠肿瘤的发生率、大小或组织学几乎没有影响。因此,四肽胃泌素对结肠肿瘤没有促进作用。